Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series

References

• Du M Q, Isaccson P G. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97–104
   PubMed Web of Science ®Google Scholar
• Stolte M, Bayerdorffer E, Morgner A, Alpen B, Wundisch T, Thiede C, et al. Helicobacter and gastric MALT lymphoma. Gut 2002; 50(Suppl 3)III19–III24
   PubMedGoogle Scholar
• Raderer M, Streubel B, Wohrer S, Hafner M, Chott A. Successful antibiotic treatment of Helicobacter pylori negative gastric MALT lymphomas. Gut 2006; 55(5): 616–618
   Web of Science ®Google Scholar
• Wohlfart S, Sebinger D, Gruber P, Buch J, Polgar D, Krupitza G, et al. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol 2004; 164: 1081–1089
   PubMed Web of Science ®Google Scholar
• Hellmig S, Fischbach W, Goebeler-Kolve M E, Folsch U R, Hampe J, Schreiber S. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 2005; 46: 869–972
   PubMed Web of Science ®Google Scholar
• Hellmig S, Vollenberg S, Goebeler-Kolve M E, Fischbach W, Hampe J, Folsch U R, et al. IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. Blood 2004; 104: 2994–2995
   PubMed Web of Science ®Google Scholar
• de Mascarel A, Ruskone-Fourmestraux A, Lavergne-Slove A, Megraud F, Dubus P, Merlio J P. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch 2005; 446: 219–224
   PubMed Web of Science ®Google Scholar
• Savio A, Franzin G, Wotherspoon A C, Zamboni G, Negrini R, Buffoli F, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both?. Blood 1996; 87: 1255–1260
   PubMed Web of Science ®Google Scholar
• Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja J L, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 2001; 86: 609–617
   PubMed Web of Science ®Google Scholar
• de Jong D, Vyth-Dreese F, Dellemijn T, Verra N, Ruskone-Fourmestraux A, Lavergne-Slove A, et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol 2001; 193: 318–324
   PubMed Web of Science ®Google Scholar
• Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponzoni M, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002; 99: 2541–2544
   PubMed Web of Science ®Google Scholar
• Fischbach W, Goebeler-Kolve M E, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53: 34–37
   PubMed Web of Science ®Google Scholar
• Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018–8024
   PubMed Web of Science ®Google Scholar
• Montalban C, Santon A, Redondo C, Garcia-Cosio M, Boixeda D, Vazquez-Sequeiros E, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 2005; 16: 1539–1544
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Gaulard P, Lavergne-Slove A, Brousse N, Flejou J F, Dordonne K, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003; 52: 1656
   PubMed Web of Science ®Google Scholar
• de Jong D, Boot H, van Heerde P, Hart G A, Taal B G. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997; 112: 1466–1474
   PubMed Web of Science ®Google Scholar
• Ruskone-Fourmestraux A, Lavergne A, Aegerter P H, Megraud F, Palazzo L, de Mascarel A, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297–303
   PubMed Web of Science ®Google Scholar
• Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M, et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000; 83: 454–457
   PubMed Web of Science ®Google Scholar
• de Jong D, Aleman B M, Taal B G, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 1999; 10: 275–280
   PubMed Web of Science ®Google Scholar
• Ruskone-Fourmestraux A, Aegerter P, Delmer A, Brousse N, Galian A, Rambaud J C. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 1993; 105: 1662–1671
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802–806
   PubMed Web of Science ®Google Scholar
• Datta Y H, Kampalath B, Binion D G. Rituximab-induced remission of a gastric MALT lymphoma. Leuk Lymphoma 2004; 45: 1297–1299
   PubMed Web of Science ®Google Scholar
• Schmidt W P, Schmitz N, Sonnen R. Conservative management of gastric lymphoma: the treatment option of choice. Leuk Lymphoma 2004; 45: 1847–1852
   PubMed Web of Science ®Google Scholar
• Koch P, Probst A, Berdel W E, Willich N A, Reinartz G, Brockmann J, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050–7059
   PubMed Web of Science ®Google Scholar